Kidney pericytes in vascular regeneration after injury
Kidney pericytes in vascular regeneration after injury
批准号:
7834787
负责人:
Jeremy S Duffield
金额:
$49.94万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-30 至 2011-07-31
关键词:
AcuteAddressAdoptive TransferAdultAffectAngiogenic FactorAreaAttenuatedBiological AssayBlood VesselsBlood capillariesBone MarrowCandidate Disease GeneCell TherapyCellsCharacteristicsChronicChronic Kidney FailureCicatrixCommunitiesDevelopmentDisciplineDiseaseDisease ProgressionEnd stage renal failureEndothelial CellsEndotheliumEngineeringEnvironmentEpidemicEyeFibroblastsFibrosisGenesGeneticGoalsHealthHealthcareHomeostasisHumanIn VitroIndividualInflammationInjuryIschemiaKidneyKidney DiseasesLeadMaintenanceMediatingMesenchymalMethodsMolecularMusMyofibroblastNatural regenerationNeuraxisNutrientOrganOxygenPericytesPlayPolyribosomesPreventionProcessProliferatingPublic HealthPublishingRNARNA InterferenceRegenerative MedicineRegulationRenal functionRenal tubule structureRoleSignal TransductionSocietiesStromal CellsTechniquesTestingTissuesTransplantationVascularizationangiogenesiscapillarycell typehealth economicsin vitro Assayin vivoinjury and repairkidney vascular structureknock-downloss of functionnovelnovel strategiespreventpublic health relevanceregenerativerepairedtooltranscription factor
中文摘要
描述(由申请人提供):该申请涉及广泛的挑战领域(11):再生医学,以及特定的挑战主题,11- dk - 102:工程或再生组织中的血管网络。慢性肾脏疾病是一种影响数百万人的公共卫生流行病,对医疗保健、社区和个人造成了严重影响。慢性肾脏疾病,以慢性炎症、实质细胞损失和纤维化以及肾功能丧失为特征。新出现的证据表明,小管周围毛细血管损失通过在肾脏中建立缺血环境来介导这些过程,导致持续的炎症。与其他器官相比,肾脏损伤特别导致毛细血管损失的原因尚不清楚。在最近发表的研究中,我们已经将周细胞描述为小管周围毛细血管的一个组成部分。周细胞是起源于间充质的细胞,与内皮细胞相邻并形成功能连接。在眼睛中,周细胞是维持毛细血管稳定和血管完整所必需的。到目前为止,由于缺乏标记物,对肾脏周细胞的描述很少。我们开发了独特的工具来研究肾脏中的周细胞。我们已经明确地表明,在损伤期间,周细胞从毛细血管中分离,增殖并分化为形成瘢痕的肾成纤维细胞。我们现在假设肾纤维化是一种功能性周细胞缺乏的状态,我们进一步假设周细胞的缺失解释了纤维化中的小管周围毛细血管稀疏。在AIM 1中,我们将通过选择性地删除肾周细胞来建立其在体内的功能。我们将验证一种新的基于细胞的治疗方法,通过过继性移植来补充肾损伤后的周细胞。我们将使用新发现的周细胞特异性标记物来询问肾损伤和纤维化是否以周细胞缺乏为特征。我们将研究周细胞的生物学作用是否为内皮细胞提供促血管生成信号,使用周细胞功能的体外实验,血管稳定实验,并通过选择性敲除可能是肾周细胞功能不可或缺的三个候选因子。在AIM 2中,我们将定义健康和疾病中周细胞的翻译概况,并验证我们假设的调节周细胞向肌成纤维细胞分化的候选转录因子。内稳态和纤维化疾病中的周细胞基因谱分析将使用一种新的、高通量的多体免疫亲和纯化技术来完成。使用候选基因方法,我们将测试三种周细胞特异性转录因子在调节周细胞向肌成纤维细胞分化中的潜在作用。我们将使用RNA沉默方法在周细胞中敲除这些因子,并在血管稳定试验中测试敲除的效果。这些建议是对肾脏周细胞功能的首次详细研究,也是理解肾脏血管稳定和再生的一种全新方法。
英文摘要
DESCRIPTION (provided by applicant): This application addresses broad Challenge Area (11): Regenerative Medicine, and specific Challenge Topic, 11-DK- 102: Vascular Network in engineered or regenerated tissues. Chronic kidney disease is a public health epidemic affecting millions that exacts a profound toll to health care, our communities and to individuals. Chronic kidney disease and is characterized by chronic inflammation, parenchymal cell loss and fibrosis and loss of kidney functions. Emerging evidence implicates peritubular capillary loss in mediating these processes by setting up an ischemic environment in the kidney that results in persistent inflammation. The reason why kidney injury, in contrast to other organs, specifically results in capillary loss is unclear. In recently published studies, we have described pericytes as an integral component of peritubular capillaries. Pericytes are cells of mesenchymal origin that lie adjacent to and make functional connections with endothelial cells. In the eye, pericytes are necessary for capillary stabilization and vascular integrity. Until now pericytes have been poorly described in the kidney due to lack of markers. We have developed unique tools to study pericytes in the kidney. We have definitively shown that during injury, pericytes detach from capillaries, proliferate and differentiate into scar-forming kidney fibroblasts. We now hypothesize that kidney fibrosis is a state of functional pericyte deficiency and we further hypothesize that pericyte loss explains peritubular capillary rarefaction in fibrosis. In AIM 1 we will establish the function of kidney pericytes in vivo by selectively deleting them. We will validate a novel cell-based therapy by attempting to replenish pericytes following kidney injury by adoptive transfer. We will ask whether kidney injury and fibrosis is characterized by pericyte deficiency using newly identified pericyte specific markers. We will examine whether the biologic role of pericytes is to provide pro-angiogenic signals to endothelium using an in vitro assay of pericyte function, the vascular stabilization assay, and and by selective knockdown of three candidate factors that may be integral to kidney pericyte function in this assay. In AIM 2 we will define the translational profile of pericytes in health and disease and validate candidate transcription factors that we hypothesize regulate differentiation of pericytes into myofibroblasts. Pericyte gene profiling in homeostasis and fibrotic disease will be accomplished using a novel, high throughput polysome immunoaffinity purification technique. Using a candidate gene approach we will test the potential role of three pericyte-specific transcription factors in regulation of differentiation of pericytes to myofibroblasts. We will knock-down these factors in pericytes using RNA silencing methods and test the effects of knock-down in the vascular stabilization assay. These proposals represent the first detailed study of pericyte function in the kidney and a completely novel approach to understanding vascular stabilization and regeneration in the kidney.
PUBLIC HEALTH RELEVANCE: Chronic kidney disease is a public health epidemic that affects millions yet despite the regenerative capacity of the kidney, many people with chronic kidney disease suffer progressive loss of function. Emerging evidence from different disciplines indicates that loss of the small blood vessels, known as capillaries that carry oxygen and nutrients to the tubules of the kidney, may be a central problem in chronic kidney disease. We have recently discovered that kidney capillaries comprising endothelial cells are also wrapped in another type of cell called pericytes. Until now pericytes in the kidney have been poorly described and their function in the kidney has not been studied. We have developed unique tools to study pericytes in mice, and in this proposal we will investigate at a cellular and molecular level the role pericytes play in the developing vasculature, maintenance of healthy vasculature and in vascular regeneration following injury of the kidney.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pericyte-endothelial cross talk in vascular stability after kidney injury
-
批准号:8369279
-
项目类别:
-
资助金额:$49.7万
-
财政年份:2012
-
负责人:Jeremy S Duffield
-
依托单位:
Kidney pericytes in vascular regeneration after injury
-
批准号:8190773
-
项目类别:
-
资助金额:$48.98万
-
财政年份:2009
-
负责人:Jeremy S Duffield
-
依托单位:
The role of Macrophage Delivered WNT Signaling in kidney injury and repair
-
批准号:8296341
-
项目类别:
-
资助金额:$35.39万
-
财政年份:2009
-
负责人:Jeremy S Duffield
-
依托单位:
The role of Macrophage Delivered WNT Signaling in kidney injury and repair
-
批准号:8188804
-
项目类别:
-
资助金额:$19.92万
-
财政年份:2009
-
负责人:Jeremy S Duffield
-
依托单位:
The role of Macrophage Delivered WNT Signaling in kidney injury and repair
-
批准号:8204422
-
项目类别:
-
资助金额:$35.39万
-
财政年份:2009
-
负责人:Jeremy S Duffield
-
依托单位:
The role of Macrophage Delivered WNT Signaling in kidney injury and repair
-
批准号:7697086
-
项目类别:
-
资助金额:$39.43万
-
财政年份:2009
-
负责人:Jeremy S Duffield
-
依托单位:
The role of Macrophage Delivered WNT Signaling in kidney injury and repair
-
批准号:7924869
-
项目类别:
-
资助金额:$18.7万
-
财政年份:2009
-
负责人:Jeremy S Duffield
-
依托单位:
DEFINING INJURIOUS & REPARATIVE MACROPHAGES IN KIDNEY INJURY AND REPAIR
-
批准号:7897665
-
项目类别:
-
资助金额:$13.57万
-
财政年份:2006
-
负责人:Jeremy S Duffield
-
依托单位:
DEFINING INJURIOUS & REPARATIVE MACROPHAGES IN KIDNEY INJURY AND REPAIR
-
批准号:7148191
-
项目类别:
-
资助金额:$13.41万
-
财政年份:2006
-
负责人:Jeremy S Duffield
-
依托单位:
DEFINING INJURIOUS & REPARATIVE MACROPHAGES IN KIDNEY INJURY AND REPAIR
-
批准号:7454307
-
项目类别:
-
资助金额:$13.67万
-
财政年份:2006
-
负责人:Jeremy S Duffield
-
依托单位:
DEFINING INJURIOUS & REPARATIVE MACROPHAGES IN KIDNEY INJURY AND REPAIR
-
批准号:7268688
-
项目类别:
-
资助金额:$13.49万
-
财政年份:2006
-
负责人:Jeremy S Duffield
-
依托单位:
DEFINING INJURIOUS & REPARATIVE MACROPHAGES IN KIDNEY INJURY AND REPAIR
-
批准号:7632227
-
项目类别:
-
资助金额:$13.57万
-
财政年份:2006
-
负责人:Jeremy S Duffield
-
依托单位:
海外基金